Exercise in Interstitial Lung Disease

Not Applicable

Completed

• Conditions: Interstitial Lung disease; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12611000416998
• Lead Sponsor: eona Dowman

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-04-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 116

Inclusion Criteria

Patients with documented interstitial lung disease, who are ambulant and suffer from dyspnoea on exertion despite maximal medical treatment

Exclusion Criteria

Patients who have a history of syncope on exertion, are too unwell to attend the hospital for exercise training or have any other comorbidities which would prevent Exercise training such as severe orthopaedic or neurological deficits or unstable cardiac disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in functional exercise capacity measured with 6 minute walk test according to standardised criteria.[At baseline, post 8 weeks intervention and 6 months following intervention.]

Secondary Outcome Measures

Name	Time	Method
Change in peripheral Muscle strength measured using a hand held dynamometer.[At baseline, post 8weeks intervention and 6 months following intervention.];Health-related Quality of Life (HRQOL) measured using with the Chronic Respiratory Disease Questionnaire (CRQ), and St George Respiratory Questionnaire idiopathic pulmonary fibrosis specific version (SGRQ-I).[At baseline, post 8 weeks intervention and 6 months following intervention.];Dyspnoea measured using the University of California San Diego Shortness of breath questionnaire (UCSD SOBQ).disease.[At baseline, post 8 weeks intervention and 6 months following intervention.];Standard spirometry, lung volumes and transfer factor for carbon monoxide (TLCO) will be measured to quantify disease severity.[Spirometry and TLCO will be measured at baseline and 6 months following intervention. Lung volumes will be measured at baseline only.];Trans-thoracic echocardiogram will be performed to quantify the degree of pulmonary hypertension.[At baseline only]